Literature DB >> 19525405

Methotrexate: the gold standard without standardisation.

Jonathan Kay, Rene Westhovens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19525405     DOI： 10.1136/ard.2008.102822

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  Treatment of rheumatoid arthritis (RA) in India-how and by whom: results from a speciality clinic-use of low-dose methotrexate (MTX) was inexplicably suboptimal.

Authors:  Anand N Malaviya; S B Gogia
Journal:  Clin Rheumatol       Date:  2016-04-28       Impact factor: 2.980

2.  Adverse drug reactions caused by methotrexate in Saudi population.

Authors:  Haya M Al-Malaq; Hussein F Al-Arfaj; Abdurhman S Al-Arfaj
Journal:  Saudi Pharm J       Date:  2012-05-19       Impact factor: 4.330

3.  Adipose mesenchymal stromal cell function is not affected by methotrexate and azathioprine.

Authors:  Pablo Mancheño-Corvo; Marcella Franquesa; Olga de la Rosa; Cristina Ramírez; Leyre García-Benzaquén; Vanessa Fernández; Ramón Menta; Aitor Beraza; Wilfried Dalemans; Martin J Hoogduijn; Eleuterio Lombardo
Journal:  Biores Open Access       Date:  2013-12-01

4.  Periodontal treatment prevents arthritis in mice and methotrexate ameliorates periodontal bone loss.

Authors:  Paul M Lübcke; Meinolf N B Ebbers; Johann Volzke; Jana Bull; Susanne Kneitz; Robby Engelmann; Hermann Lang; Bernd Kreikemeyer; Brigitte Müller-Hilke
Journal:  Sci Rep       Date:  2019-05-31       Impact factor: 4.379

5.  The optimal dosage of pefcitinib for the treatment of active rheumatoid arthritis: A protocol for an updated network meta-analysis.

Authors:  Yuyi Zhou; Chunfang Sun; Chunyan Chen
Journal:  Medicine (Baltimore)       Date:  2021-02-19       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.